Researchers discover new form of hereditary prostate cancer
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
-
-
New genomic method to track disease outbreaks globally
On Jul. 9, 2026, Wellcome Sanger Institute scientists and their collaborators announced Phylo-Plex, a new computational method to…
-
Surgeons Use Teleoperated Humanoid Robots to Perform Live Surgery – a World First
On Jul. 8, 2026, a team of surgeons at the University of California San Diego report that for…
-
Agriculture | Biotechnology | Environmental | EPA | FDA | Forestry | Genomics | Implants | Infectious Disease | Marine Science | Medical Device | Oncology | Organ Transplant | Organoids | Pharmaceutical | Quantum | Robotics | Software | Stem Cell | U.S. Congress | Vaccine | Veterinary | Women's Health
New PhD Admissions Data Show Threat to U.S. STEM Workforce, Breakthroughs and Innovations
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
-
Ebola continues to spread in DRC as death toll passes 500, WHO warns
On Jul. 7, 2026, the World Health Organization (WHO) reported that the outbreak of the deadly Bundibugyo species of…
-
Biotechnology | Disease | FDA | Therapeutics
US FDA approves Vera’s kidney disease drug
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
-
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
On Jul. 7, 2026, Vertex Pharmaceuticals and Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development…
-
Novartis to acquire Myricx Bio for $1.5 Billion
On Jul. 6, 2026, Novartis announced it has reached an agreement to acquire Myricx Bio for up to…
-
Biotechnology | Disease | Neurology | Oncology | Rare Disease | Stem Cell
New CRISPR Method Makes It Possible to Control Protein Production in Cells
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
-
Visby Medical Receives FDA Clearance for the First At-Home PCR for Multiple Respiratory Viruses
On Jul. 2, 2026, Visby Medical, the at-home diagnostics company, announced U.S. Food and Drug Administration (FDA) clearance…
-
Immunotherapy shows promise in treating deadly brain tumours
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
-
Alzheimer’s proteins in blood linked to midlife cognition
On Jul. 1, 2026, the National Institutes of Health (NIH) reported that a study found that people in…
-
World’s first synthetic cell with a complete life cycle could revolutionize biological engineering
On Jul. 1, 2026, Associate Professors Kate Adamala and Aaron Engelhart and their teams at the College of…
-
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery Worth $600 million
On Jul. 1, 2026, Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic…
-
Professor Chih-Ying Su Leaves U.S. to join Shenzhen Medical Academy of Research and Translation
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
HHS Secretary Signs COVID-19 Emergency Use Authorization Declaration Terminations
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
-
Billions of doses later: Global review confirms mRNA vaccines are safe, effective and full of promise
On Jun. 30, 2026, a sweeping global review led by researchers at the University of British Columbia has…
-
EU Approves first tumour agnostic HER2-directed therapy for Breast Cancer
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
-
China’s first AI-powered cancer vaccine production line set to launch in Beijing
On Jun. 29, 2026, China announced it has broken ground on what developers say is the country’s first…
-
Hanyang University Researchers Develop AI-designed Shape-Shifting Microneedles for Diabetic Wound Healing
On Jun. 26, 2026, Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Researchers report developing…
-
Merck Agrees to Acquire Bio-Techne for $11.3 Billion
On Jun. 25, 2026, Merck and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies,…
-
Self-propelled actin filaments: Novel structures driving spontaneous cell morphogenesis
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
-
Colossal Biosciences and US Fish and Wildlife Service Partner to Biobank Every Endangered Species
On Jun. 25, 2026, Colossal Biosciences US Fish and Wildlife Service announced a partnership that aims to collect…
-
Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds
On Jun. 24, 2026, A University of Southern California (USC)-led study finds Alzheimer’s disease and related dementias will…
-
In shift, Pentagon grants flu vaccine exceptions to military services, some federal agencies
On Jun. 24, 2026, the Pentagon announced it has updated the guidance on the influenza vaccination, offering exceptions…
-
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
-
Ancient DNA found on cave walls In Portugal and Spain
On Jun. 24, 2026, researchers from the Max Planck Institute for Evolutionary Anthropology report that ancient human DNA…
-
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
-
high-endurance DNA origami snap-through switch for functional nanoscale control
On Jun. 24, 2026, researchers from the Technical University of Munich presented a DNA origami–based, mechanically bistable snap-through…
